Show simple item record

dc.contributor.authorGrand, H.*
dc.contributor.authorSamson, Anne-Laure*
dc.contributor.authorAulois-Griot, M.*
dc.date.accessioned2014-11-26T09:02:12Z
dc.date.available2014-11-26T09:02:12Z
dc.date.issued2014-11
dc.identifier.urihttps://basepub.dauphine.fr/handle/123456789/14312
dc.language.isoenen
dc.subjectDrugsen
dc.subjectHealth expendituresen
dc.subject.ddc334en
dc.subject.classificationjelI.I1.I12en
dc.subject.classificationjelI.I1.I11en
dc.titlePSY72 – Orphan Drug Pricing In France: Influence of Main Factorsen
dc.typeArticle accepté pour publication ou publié
dc.contributor.editoruniversityotherUniversité de Bordeaux;France
dc.description.abstractenOrphan drugs (OD) require considerable expenditures, which causes difficulties in their market access. For several years, the price of these new therapies has often been criticized and considered as too high. However few studies about OD pricing mechanisms are available. The aim of the paper is to highlight the main factors that influence OD pricing in France.en
dc.relation.isversionofjnlnameValue in Health
dc.relation.isversionofjnlvol17en
dc.relation.isversionofjnlissue7en
dc.relation.isversionofjnldate2014-11
dc.relation.isversionofjnlpagesA534en
dc.relation.isversionofdoi10.1016/j.jval.2014.08.1702en
dc.relation.isversionofjnlpublisherElsevieren
dc.subject.ddclabelEconomie socialeen
dc.relation.forthcomingnonen
dc.relation.forthcomingprintnonen
dc.description.halcandidateoui
dc.description.readershiprecherche
dc.description.audienceInternational
hal.person.labIds*
hal.person.labIds163511*
hal.person.labIds*
hal.identifierhal-01685910*


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record